Robertw Keane News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ZyVersa Therapeutics (ZVSA) Publishes New White Paper Detailing the Role of Inflammasomes and ASC Specks in Neurological Diseases

ZyVersa Therapeutics (ZVSA) Publishes New White Paper Detailing the Role of Inflammasomes and ASC Specks in Neurological Diseases
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRivero vaccariStephenc gloverRobertw keaneZyversa therapeutics incMichaelj fox foundationUniversity of miami miller school medicineZyversa therapeuticsJuan pablo de rivero vaccariMiami miller school

ZyVersa Therapeutics Announces Peer-Reviewed Article

Activation of the inflammasome/ASC speck pathway has a vital role in synaptic degeneration in Alzheimer’s Disease (AD)..

United statesCasey mcdonaldReginat vontellStephenc gloverRobertw keaneDave schemeliaUniversity of miami miller school medicineTranslational research clinical interventionsBrain endowment bankZyversa therapeutics incResearch assistant professorSecurities exchangeTiberend strategic advisors incVersa therapeuticsTranslational researchAssociate director

ZyVersa Therapeutics (ZVSA) Reports Peer-Reviewed Article Supporting the Therapeutic Potential of Targeting ASC Specks During Progression of Alzheimer s Disease

ZyVersa Therapeutics (ZVSA) Reports Peer-Reviewed Article Supporting the Therapeutic Potential of Targeting ASC Specks During Progression of Alzheimer s Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRobertw keaneReginat vontellStephenc gloverResearch assistant professorUniversity of miami miller school medicineTranslational research clinical interventionsBrain endowment bankZyversa therapeutics incZyversa therapeuticsTranslational researchAssociate directorMiami miller schoolNeurological surgeryInflammatory disease scientific advisoryClinical interventions

ZyVersa Therapeutics Announces Peer-Reviewed Article Supporting the Therapeutic Potential of Targeting ASC Specks During Progression of Alzheimer s Disease Seite 1

24.01.2024 - Research demonstrated that activation of the inflammasome/ASC speck pathway has a vital role in synaptic degeneration in Alzheimer’s Disease (AD).ZyVersa is developing IC 100, a monoclonal antibody targeting inflammasome ASC specks to block . Seite 1

United statesRobertw keaneReginat vontellZyversa therapeutics incBrain endowment bankUniversity of miami miller school medicineTranslational research clinical interventionsResearch assistant professorVersa therapeuticsTranslational researchAssociate directorMiami miller schoolNeurological surgeryInflammatory disease scientific advisory

ZyVersa Therapeutics Announces New Peer-Reviewed Publication Reinforcing the Rationale for Inhibiting ASC Specks with IC 100 to Attenuate Spread of Inflammation into Surrounding Tissues

The paper, published in Pharmaceuticals, demonstrates that pyrin inflammasome-mediated inflammation induced by traumatic brain injury contributes to cardiovascular co-morbidities through systemic.

United statesRivero vaccariStephenc gloverRobertw keaneCasey mcdonaldDave schemeliaZyversa therapeutics incTranslational researchTiberend strategic advisors incUniversity of miami miller school medicineDepartment of neurological surgerySecurities exchangeVersa therapeuticsMiami miller schoolCardiac inflammasome axisTraumatic brain injury